Targeted Medical Pharma Inc (TRGM) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
2980 BEVERLY GLEN CIRCLE LOS ANGELES, CA 90077 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 83 | 12 | 492 | 327 | ||
| Cash and cash equivalents | 83 | 12 | 492 | 327 | ||
| Receivables | 328 | 203 | 269 | 354 | ||
| Inventory, net of allowances, customer advances and progress billings | 92 | 127 | 596 | 478 | ||
| Inventory | 92 | 127 | 596 | 478 | ||
| Prepaid expense | 901 | ✕ | ||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | 212 | ||
| Other current assets | 330 | 192 | 372 | ✕ | ||
| Other undisclosed current assets | 1,228 | |||||
| Total current assets: | 833 | 534 | 2,630 | 2,599 | ||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 54 | 107 | 236 | 340 | ||
| Long-term investments and receivables | (386) | |||||
| Due from related parties | (386) | |||||
| Intangible assets, net (including goodwill) | 1,540 | 1,859 | 2,133 | 2,319 | ||
| Intangible assets, net (excluding goodwill) | 1,540 | 1,859 | 2,133 | 2,319 | ||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | 27 | ||
| Other undisclosed noncurrent assets | 6,877 | |||||
| Total noncurrent assets: | 1,594 | 1,966 | 2,368 | 9,177 | ||
| TOTAL ASSETS: | 2,427 | 2,500 | 4,998 | 11,775 | ||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 10,050 | 12,731 | 9,720 | 7,024 | ||
| Accounts payable | 1,864 | 1,460 | 1,497 | |||
| Accrued liabilities | 8,186 | 7,274 | 5,655 | |||
| Employee-related liabilities | 3,997 | 2,568 | ||||
| Accounts payable and other accrued liabilities | ✕ | ✕ | 7,024 | |||
| Debt | 2,119 | 1,093 | 1,458 | |||
| Derivative instruments and hedges, liabilities | 1 | 18 | 29 | |||
| Due to related parties | 2,504 | 2,504 | 5,033 | |||
| Deferred tax liabilities | 70 | |||||
| Other undisclosed current liabilities | (3,997) | 53 | 188 | |||
| Total current liabilities: | 14,675 | 12,350 | 11,261 | 12,315 | ||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 104 | 122 | 755 | |||
| Long-term debt, excluding current maturities | 104 | 122 | 755 | |||
| Liabilities, other than long-term debt | 567 | 1,463 | ||||
| Deferred tax liabilities, net | 1,077 | |||||
| Due to related parties | 567 | 386 | ||||
| Total noncurrent liabilities: | 671 | 122 | 755 | 1,463 | ||
| Total liabilities: | 15,346 | 12,472 | 12,015 | 13,777 | ||
| Stockholders' equity | ||||||
| Stockholders' equity attributable to parent, including: | (12,895) | (9,972) | (7,018) | (2,002) | ||
| Common stock | 28 | 27 | 26 | 23 | ||
| Additional paid in capital | 17,038 | 16,919 | 15,979 | 11,660 | ||
| Accumulated deficit | (29,961) | (26,917) | (23,022) | (13,685) | ||
| Warrants and rights outstanding | 188 | |||||
| Other undisclosed stockholders' equity attributable to parent | (188) | |||||
| Stockholders' equity attributable to noncontrolling interest | (23) | |||||
| Total stockholders' equity: | (12,919) | (9,972) | (7,018) | (2,002) | ||
| TOTAL LIABILITIES AND EQUITY: | 2,427 | 2,500 | 4,998 | 11,775 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 5,261 | 7,112 | 9,556 | 7,296 | |
| Cost of revenue (Cost of Goods and Services Sold) | (2,096) | (2,217) | (2,989) | (3,201) | |
| Gross profit: | 3,165 | 4,896 | 6,566 | 4,095 | |
| Operating expenses | (5,195) | (7,507) | (10,407) | (10,235) | |
| Operating loss: | (2,030) | (2,611) | (3,841) | (6,140) | |
| Nonoperating income (expense) | (1,037) | (1,218) | 170 | (6,632) | |
| Interest and debt expense | 1,174 | 11 | (215) | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (1,174) | (11) | 215 | ||
| Loss from continuing operations before equity method investments, income taxes: | (3,067) | (3,829) | (3,671) | (12,772) | |
| Income from equity method investments | 734 | ||||
| Loss from continuing operations before income taxes: | (3,067) | (3,095) | (3,671) | (12,772) | |
| Income tax expense (benefit) | (66) | (5,667) | 3,186 | ||
| Net loss: | (3,067) | (3,161) | (9,338) | (9,586) | |
| Net income attributable to noncontrolling interest | 23 | ||||
| Other undisclosed net loss attributable to parent | (734) | ||||
| Net loss available to common stockholders, diluted: | (3,044) | (3,895) | (9,338) | (9,586) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|
| Net loss: | (3,067) | (3,161) | (9,338) | (9,586) | |
| Comprehensive loss: | (3,067) | (3,161) | (9,338) | (9,586) | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 23 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (3,044) | (3,161) | (9,338) | (9,586) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.